AHA GUIDELINES Bundle (free trial)

High Blood Pressure - Merck Supported

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1539869

Contents of this Issue

Navigation

Page 79 of 87

80 Complications of Management Table 26. Intravenous Antihypertensive Drugs for Treatment of Hypertensive Emergencies Class Drug(s) Usual Dose Range CCB— dihydropyridines Nicardipine Initial 5 mg/h, increasing every 5 min by 2.5 mg/h to maximum 15 mg/h Clevidipine Initial 1–2 mg/h, doubling every 90 s until BP approaches target, then increasing by less than double every 5–10 min; maximum dose 21 mg/h; maximum duration 72 h Vasodilators Nitric-oxide dependent Sodium nitroprusside Initial 0.3–0.5 mcg/kg/min; increase in increments of 0.5 mcg/kg/min q 5 min to achieve BP target; maximum dose 10 mcg/kg/min; duration of treatment as short as possible Nitroglycerin Initial 5 mcg/min; increase in increments of 5 mcg/min every 3–5 min to a maximum rate of 200 mcg/min Vasodilators Direct Hydralazine Initial 10 mg via slow IV infusion (maximum initial dose 20 mg ); repeat every 4–6 h as needed. Adjust rate up to total cumulative dose of 200 mg/24 hours. Adrenergic blockers Beta-1 receptor selective antagonist Esmolol Loading dose 500–1000 mcg/kg/min over 1 min followed by a 50-mcg/kg/min infusion. For additional dosing, the bolus dose is repeated, and the infusion increased in 50-mcg/kg/min increments as needed to a maximum of 300 mcg/kg/min. 6.2.1. Medications for Hypertensive Emergencies

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - High Blood Pressure - Merck Supported